US 10563259
Method of treatment based on polymorphisms of the KCNQ1 gene
granted A61KA61K31/454A61K31/496
Quick answer
US patent 10563259 (Method of treatment based on polymorphisms of the KCNQ1 gene) held by VANDA PHARMACEUTICALS INC. expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/454, A61K31/496, A61K31/519, A61P